Please provide your email address to receive an email when new articles are posted on . CagriSema is a once-weekly combination of semaglutide and cagrilinitide. For adults with overweight or obesity, ...
Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback